The Dutch national living donor kidney exchange program

被引:125
作者
de Klerk, M [1 ]
Keizer, KM
Claas, FHJ
Witvliet, M
Haase-Kromwijk, BJJM
Weimar, W
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med Transplantat, Rotterdam, Netherlands
[2] Dutch Transplantat Fdn, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Natl Reference Lab Histocompatibil, Leiden, Netherlands
关键词
kidney transplantation; living donors; paired kidney exchange;
D O I
10.1111/j.1600-6143.2005.01024.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The wait time for deceased-donor kidney transplantation has increased to 4-5 years in the Netherlands. Strategies to expand the donor pool include a living donor kidney exchange program. This makes it possible that patients who cannot directly receive a kidney from their intended living donor, due to ABO blood type incompatibility or a positive cross match, exchange donors in order to receive a compatible kidney. All Dutch kidney transplantation centers agreed on a common protocol. An independent organization is responsible for the allocation, cross matches are centrally performed and exchange takes place on an anonymous basis. Donors travel to the recipient centers. Surgical procedures are scheduled simultaneously. Sixty pairs participated within 1 year. For 9 of 29 ABO blood type incompatible and 17 of 31 cross match positive combinations, a compatible pair was found. Five times a cross match positive couple was matched to a blood type incompatible one, where the recipients were of blood type O. The living donor kidney exchange program is a successful approach that does not harm any of the candidates on the deceased donor kidney waitlist. For optimal results, both ABO blood type incompatible and cross match positive pairs should participate.
引用
收藏
页码:2302 / 2305
页数:4
相关论文
共 12 条
[1]  
de Klerk M, 2004, ETHICAL, LEGAL, AND SOCIAL ISSUES IN ORGAN TRANSPLANTATION, P255
[2]   United network for organ sharing [J].
Delmonico, FL ;
Morrissey, PE ;
Lipkowitz, GS ;
Stoff, JS ;
Himmelfarb, J ;
Harmon, W ;
Pavlakis, M ;
Mah, H ;
Goguen, J ;
Luskin, R ;
Milford, E ;
Basadonna, G ;
Chobanian, M ;
Bouthot, B ;
Lorber, M ;
Rohrer, RJ .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) :1628-1634
[3]   The nondirected living donor program: A model for cooperative donation, recovery and allocation of living donor kidneys [J].
Gilbert, JC ;
Brigham, L ;
Scott, D ;
Batty, DS ;
Veatch, RM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (01) :167-174
[4]   Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients [J].
Jordan, SC ;
Vo, A ;
Bunnapradist, S ;
Toyoda, M ;
Peng, A ;
Puliyanda, D ;
Kamil, E ;
Tyan, D .
TRANSPLANTATION, 2003, 76 (04) :631-636
[5]   Starting a crossover kidney transplantation program in the Netherlands: Ethical and psychological considerations [J].
Kranenburg, LW ;
Visak, T ;
Weimar, W ;
Zuidema, W ;
de Klerk, M ;
Hilhorst, M ;
Passchier, H ;
Ijzermans, JNM ;
Busschbach, JJV .
TRANSPLANTATION, 2004, 78 (02) :194-197
[6]   US surgeons do first "triple-swap" kidney transplantation [J].
McLellan, F .
LANCET, 2003, 362 (9382) :456-456
[7]   Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients [J].
Montgomery, RA ;
Zachary, AA ;
Racusen, LC ;
Leffell, MS ;
King, KE ;
Burdick, J ;
Maley, WR ;
Ratner, LE .
TRANSPLANTATION, 2000, 70 (06) :887-895
[8]   Exchange living-donor kidney transplantation: Diminution of donor organ shortage [J].
Park, K ;
Lee, JH ;
Huh, KH ;
Kim, SI ;
Kim, YS .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (10) :2949-2951
[9]  
RAPAPORT FT, 1986, TRANSPL P, V18, P5
[10]   Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit [J].
Ross, LF ;
Zenios, S .
TRANSPLANTATION, 2004, 78 (05) :641-646